DCT and melanoma: In support of this data, it was demonstrated that immunizing mice with human tyrosinase-related Protein 2 or utilizing the vaccinia virus to deliver their own tyrosinase-related Protein 1 prompts the development of vitiligo and imparts a shield of defense against melanoma.